Association of Alzheimer's genetic loci with mild behavioral impairment
Authors:
- 30 October 2018
- journal article
- research article
- Published by Wiley in American Journal of Medical Genetics Part B: Neuropsychiatric Genetics
- Vol. 177 (8) , 727-735
Abstract
Mild behavioral impairment (MBI) describes the emergence of later‐life neuropsychiatric symptoms (NPS) as an at‐risk state for incident cognitive decline and dementia, and for some as a potential manifestation of prodromal dementia. How NPS mechanistically link to the development of mild cognitive impairment and Alzheimer's disease (AD) is not fully understood, with potential mechanisms including shared risk factors related to both NPS and cognitive impairment, or AD pathology promoting NPS. This is the first exploratory study to examine whether AD genetic loci as a genetic risk score (GRS), or individually, are a shared risk factor with MBI. Participants were 1,226 older adults (aged 72–79; 738 males; 763 normal cognition) from the Personality and Total Health Through Life project. MBI was approximated in accordance with Criterion 1 of the ISTAART‐AA diagnostic criteria using a transformation algorithm for the neuropsychiatric inventory. A GRS was constructed from 25 AD risk loci. Binomial logistic regression adjusting for age, gender, and education examined the association between GRS and MBI. A higher GRS and APOE*ε4 were associated with increased likelihood of affective dysregulation. Nominally significant associations were observed between MS4A4A‐rs4938933*C and MS4A6A‐rs610932*G with a reduced likelihood of affective dysregulation; ZCWPW1‐rs1476679*C with a reduced likelihood of social inappropriateness and abnormal perception/thought content; BIN1‐rs744373*G and EPHA1‐rs11767557*C with higher likelihood of abnormal perception/thought content; NME8‐rs2718058*G with a reduced likelihood of decreased motivation. These preliminary findings suggest a common genetic etiology between MBI and traditionally recognized cognitive problems observed in AD and improve our understanding of the pathophysiological features underlying MBI.Keywords
All Related Versions
Funding Information
- National Health and Medical Research Council (1002560 1102028)
- Hotchkiss Brain Institute
- Australian Research Council (CE1101029)
- National Health and Medical Research Council (1002160, 179805)
This publication has 64 references indexed in Scilit:
- Increased expression of BIN1 mediates Alzheimer genetic risk by modulating tau pathologyMolecular Psychiatry, 2013
- Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapyNature Reviews Neurology, 2013
- Evaluation of genetic risk score models in the presence of interaction and linkage disequilibriumFrontiers in Genetics, 2013
- Genome-wide association study of Alzheimer's disease with psychotic symptomsMolecular Psychiatry, 2011
- Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's diseaseNature Genetics, 2011
- Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's diseaseNature Genetics, 2011
- The Neuropsychiatric Inventory-Clinician rating scale (NPI-C): reliability and validity of a revised assessment of neuropsychiatric symptoms in dementiaInternational Psychogeriatrics, 2010
- Genome-wide Analysis of Genetic Loci Associated With Alzheimer DiseaseJAMA, 2010
- Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's diseaseNature Genetics, 2009
- The Neuropsychiatric InventoryNeurology, 1994